Affinity labeling of cysteine-mutants evidences contact residues in modeled receptor binding sites.
To investigate the topology of binding sites in two ionotropic receptors, we have initiated a strategy combining affinity labeling with cysteine-scanning mutagenesis. For the GABAA receptor we have used reactive derivatives of non-competitive blockers (NCBs) to explore interacting positions in its channel. The polypeptide positions of the M2 segment of the alpha1 subunit which we mutated into cysteine were selected for their established accessibility, as determined by the substituted-cysteine accessibility method (SCAM). Using the Xenopus oocyte expression system, we show that receptors containing mutations V257C and S272C are inactivated by several reactive NCBs. These position-selective inactivations lead to an analysis of NCB binding in the channel. For the NMDA receptor glycine-binding site, the prototype antagonist L-701,324 was derivatized at different positions with different reactive groups. The receptor positions to mutate into cysteine were selected after a 3-D homology model. The observed receptor inactivations are mutant- and probe-selective, leading to an unambiguous chemical docking of the antagonist pharmacophore and supporting the model. The site-specificity of the inactivating reactions is assessed by protection experiments and by mutant to wild-type (WT) comparisons. The scope and limitations of the method are briefly discussed.
Perret
P
P
Texas A&M University, Department of Biology, College Station, Texas 77843, USA.
Laube
B
B
Schemm
R
R
Betz
H
H
Goeldner
M
M
Foucaud
B
B
D000345:Affinity Labels; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D001665:Binding Sites; D003545:Cysteine / Q000235:genetics*; D058787:GABA-A Receptor Antagonists; D005998:Glycine / Q000378:metabolism; D008024:Ligands; D009154:Mutation; D009865:Oocytes / Q000502:physiology; D015363:Quinolones / Q000494:pharmacology; D011963:Receptors, GABA-A / Q000378:metabolism*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014982:Xenopus laevis
D000345:Affinity Labels; D014151:Anti-Anxiety Agents; D058787:GABA-A Receptor Antagonists; D008024:Ligands; D015363:Quinolones; D011963:Receptors, GABA-A; D016194:Receptors, N-Methyl-D-Aspartate; C094635:L 701324; D003545:Cysteine; D005998:Glycine